Brown University
Providence, Rhode Island, 02912, United States
NCT Number: NCT00107575
To test the effectiveness of an smoking cessation treatment for smokers who also drink alcohol heavily.
Looking for future studies?
Notify Me18 year–95 year
All sexes
Interventional
Phase 2
Providence, Rhode Island, 02912, United States
Heavy alcohol use frequently co-occurs with cigarette smoking and may impede smoking cessation. This clinical trial examined whether smoking cessation treatment that incorporates brief alcohol intervention can improve smoking cessation outcomes (7-day verified point prevalence abstinence) and reduce drinks consumed per week. Heavy drinkers seeking smoking cessation treatment were assigned by urn randomization to receive, along with 8-weeks of nicotine replacement therapy, either a 4-session standard smoking cessation treatment (ST, n = 119) or standard treatment of equal intensity that incorporated brief alcohol intervention (ST-BI, n = 117).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard smoking cessation treatment with nicotine patch plus a brief alcohol-focused intervention
Behavioral smoking cessation counseling and nicotine patch.
Time frame: 26 weeks
7 days of smoking abstinence confirmed biochemically at 26 week post quit attempt
Time frame: 16 weeks
7 days of smoking abstinence confirmed biochemically at 16 weeks
Time frame: 8 weeks
7 days of smoking abstinence confirmed biochemically at 8 weeks
Time frame: 2 weeks
7 days of smoking abstinence confirmed biochemically at 2 weeks
Time frame: At 2, 8, 16, and 26-week follow-ups
Average number of standard alcoholic drinks consumed per week over each 2-week period across the 26 weeks of follow-up as assessed by the Timeline Followback Interview. Standard alcoholic drink is defined as 12 oz of beer, 5 oz of wine, or 1.5 ounces of liquor.
Brown University
Other
Improving Smoking Cessation Outcomes in Heavy Drinkers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737288
Behavior, Chemically-Induced Disorders
Izmir, Turkey (Türkiye)
View Trial DetailsNCT03950427
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT04417595
Chemically-Induced Disorders, Female Urogenital Diseases and Pregnancy Complications
Nashville, Tennessee, United States
View Trial DetailsNCT04033237
Chemically-Induced Disorders, Mental Disorders
Lexington, Kentucky, United States
View Trial Details